We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Reply letter to Adeli and Jazi - "Intravenous N-acetylcysteine in respiratory disease with abnormal mucus secretion".
- Authors
TANG, W.; ZHU, D.; WU, F.; XU, J.-F.; YANG, J.-P.; DENG, Z.-P.; CHEN, X.-B.; PAPI, A.; QU, J.-M.
- Abstract
The article focuses on responding to comments regarding missing data in the study, emphasizing that additional details are available on clinicaltrial.gov. It clarifies that the study aimed to demonstrate the efficacy and safety of an intravenous formulation of N-acetylcysteine (NAC) in hospitalized patients with respiratory conditions and outlines the reasons for participant discontinuation and the incidence of treatment-related adverse events observed during the trial.
- Subjects
RESPIRATORY diseases; ACETYLCYSTEINE; DRUG side effects; MUCUS; SECRETION
- Publication
European Review for Medical & Pharmacological Sciences, 2024, Vol 28, Issue 10, p3477
- ISSN
1128-3602
- Publication type
Article